| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 8490 | 2020 |
| Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the … AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ... Clinical infectious diseases 63 (5), e61-e111, 2016 | 3914 | 2016 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1815 | 2021 |
| Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial SM Opal, PF Laterre, B Francois, SP LaRosa, DC Angus, JP Mira, ... Jama 309 (11), 1154-1162, 2013 | 891 | 2013 |
| Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of … NP O’Grady, PS Barie, JG Bartlett, T Bleck, K Carroll, AC Kalil, P Linden, ... Critical care medicine 36 (4), 1330-1349, 2008 | 750 | 2008 |
| Treating COVID-19—off-label drug use, compassionate use, and randomized clinical trials during pandemics AC Kalil Jama 323 (19), 1897-1898, 2020 | 628 | 2020 |
| Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients AC Kalil, J Levitsky, E Lyden, J Stoner, AG Freifeld Annals of internal medicine 143 (12), 870-880, 2005 | 524 | 2005 |
| Influenza virus-related critical illness: pathophysiology and epidemiology AC Kalil, PG Thomas Critical care 23 (1), 258, 2019 | 458 | 2019 |
| Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis PQ Eichacker, C Parent, A Kalil, C Esposito, X Cui, SM Banks, ... American journal of respiratory and critical care medicine 166 (9), 1197-1205, 2002 | 431 | 2002 |
| American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID‐19 pandemic: version 2 TR Mikuls, SR Johnson, L Fraenkel, RJ Arasaratnam, LR Baden, ... Arthritis & rheumatology 72 (9), e1-e12, 2020 | 430 | 2020 |
| Long-term consequences of COVID-19: research needs D Yelin, E Wirtheim, P Vetter, AC Kalil, J Bruchfeld, M Runold, G Guaraldi, ... The Lancet Infectious Diseases 20 (10), 1115-1117, 2020 | 389 | 2020 |
| Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial JL Vincent, DC Angus, A Artigas, A Kalil, BR Basson, HH Jamal, ... Critical care medicine 31 (3), 834-840, 2003 | 365 | 2003 |
| Cryptococcus neoformans in Organ Transplant Recipients: Impact of Calcineurin-Inhibitor Agents on Mortality N Singh, BD Alexander, O Lortholary, F Dromer, KL Gupta, GT John, ... The Journal of infectious diseases 195 (5), 756-764, 2007 | 295 | 2007 |
| An Immune Reconstitution Syndrome-Like Illness Associated withCryptococcus neoformans Infection in Organ Transplant Recipients N Singh, O Lortholary, BD Alexander, KL Gupta, GT John, K Pursell, ... Clinical infectious diseases 40 (12), 1756-1761, 2005 | 274 | 2005 |
| Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator‐associated pneumonia DC Berton, AC Kalil, PJZ Teixeira Cochrane Database of Systematic Reviews, 2012 | 269 | 2012 |
| Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit AC Kalil, DF Florescu Critical care medicine 37 (8), 2350-2358, 2009 | 248 | 2009 |
| The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States CS Kraft, AL Hewlett, S Koepsell, AM Winkler, CJ Kratochvil, LA Larson, ... Clinical Infectious Diseases 61 (4), 496-502, 2015 | 225 | 2015 |
| Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta … AC Kalil, TC Van Schooneveld, PD Fey, ME Rupp Jama 312 (15), 1552-1564, 2014 | 207 | 2014 |
| What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression DF Florescu, F Qiu, MA McCartan, C Mindru, PD Fey, AC Kalil Clinical infectious diseases 54 (5), 670-680, 2012 | 191 | 2012 |
| Infectious Diseases Society of America (IDSA) position statement: why IDSA did not endorse the surviving sepsis campaign guidelines IDSA Sepsis Task Force Kalil Andre C Gilbert David N Winslow Dean L Masur ... Clinical Infectious Diseases 66 (10), 1631-1635, 2018 | 187 | 2018 |
